Original Literature | Model OverView |
---|---|
Publication
Title
Macrophage differentiation and function in health and disease.
Affiliation
Division of Cellular and Molecular Pathology, Department of Cellular Function,Niigata University Graduate School of Medical and Dental Sciences, Niigata,Japan. mnaito@med.niigata-u.ac.jp
Abstract
Macrophages exist in almost all animals. In some invertebrates, mesenchymalcells, endothelial cells or fibroblast-like cells can transform intomacrophages. In vertebrates, primitive macrophages first develop in yolk sachematopoiesis and differentiate into fetal macrophages. Monocytes aredifferentiated from hematopoietic stem cells in the late stage of fetalhematopoietic organs and bone marrow. Macrophages serve as an effector inmetabolism and host defense. Depletion of macrophages severely reduced bilirubinproduction and host resistance to infection. Macrophage scavenger receptors areinvolved in host defense. Macrophage growth factors are critical for macrophagedifferentiation and function. In macrophage colony-stimulating factor(M-CSF)-deficient osteopetrotic mice, monocytes, tissue macrophages andosteoclasts are deficient. Granulocyte-macrophage colony-stimulating factor(GM-CSF)-deficient mice develop alveolar proteinosis due to impaired surfactantcatabolism by alveolar macrophages. Accumulation of glucocerebroside inmacrophages due to the deficiency of glucocerebrosidase in lysosomes producesGaucher cells. Macrophages in the arterial wall incorporate chemically modifiedlow-density lipoprotein (LDL) and transform into foam cells. Binding oxidizedLDL to liver X receptor alpha (LXRalpha) upregulates the expression of itstarget genes, which act as cholesterol removers from macrophages. Inflammatorysignals downregulate the expression of LXRalpha and enhance lipid accumulation.Thus, macrophages play a pivotal role in metabolism and host defense.
PMID
18251777
|
Entity
LPS
--
MO000016882
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m155666
10
infinite
0
TRANSPATH | MO000016882 |
--
Modified lipoprotein
--
MO000017793
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2549
10
infinite
0
TRANSPATH | MO000017793 |
--
cholesterol
--
MO000056221
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m360460
10
infinite
0
TRANSPATH | MO000056221 |
--
MSR-A
--
MO000116148
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m359003
10
infinite
0
Affymetrix | 208422_at |
Ensembl | ENSG00000038945 |
HGNC | MSR1 |
InterPro | IPR003543 |
OMIM | 153622 |
PIR | A38415 |
PROSITE | PS00420 |
Proteome | HumanPSD/MSR1 |
RefSeq | NM_002445 |
TRANSPATH | MO000116148 |
Unigene | Hs.147635 |
UniProt | P21757 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
Non-heme protein
--
e11
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
GM-CSF: GM-CSFR
--
e12
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m12
0
infinite
0
--
cytokine
--
e13
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m13
0
infinite
0
--
csml-variable:Double
m14
10
infinite
0
Affymetrix | 1425434_a_at |
Ensembl | ENSMUSG00000025044 |
MGD | Msr1 |
Proteome | HumanPSD/Msr1 |
RefSeq | NM_031195 |
TRANSFAC | G006438 |
Unigene | Mm.1227 |
--
InlA R
--
e15
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m15
0
infinite
0
--
Listeria ligand
--
e16
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m16
0
infinite
0
--
Listeria ligand: CR3
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m17
0
infinite
0
--
Modified lipoprotein: MARCO
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m18
0
infinite
0
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
LPS: MSR-A
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
LPS: CD14
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m21
0
infinite
0
--
lipoteichoic acid
--
e22
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m22
0
infinite
0
--
lipoteichoic acid: MSR-A
--
e23
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m23
0
infinite
0
--
Modified lipoprotein: MSR-A
--
e24
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m24
0
infinite
0
--
oxLDL: Scavenger receptor
--
e25
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m25
0
infinite
0
--
LXRalpha
--
e26
cso30:c:mRNA
cso30:i:CC_Nucleolus
--
csml-variable:Double
m26
0
infinite
0
--
mannose receptor
--
e27
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m27
0
infinite
0
--
csml-variable:Double
m28
0
infinite
0
--
Cerezyme: mannose receptor
--
e29
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
LXR
--
e30
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m30
0
infinite
0
--
csml-variable:Double
m31
0
infinite
0
--
LXR {activated}: RXR
--
e32
cso30:c:Complex
cso30:i:CC_NuclearOuterMembrane
--
csml-variable:Double
m32
0
infinite
0
--
hormone response element
--
e33
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m33
0
infinite
0
--
hormone response element: LXR {activated}: RXR
--
e34
cso30:c:Complex
cso30:i:CC_NuclearEnvelopeLumen
--
--
csml-variable:Double
m34
0
infinite
0
--
csml-variable:Double
m35
0
infinite
0
--
LXR {activated}
--
e36
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m36
0
infinite
0
--
ABCA1
--
e37
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m37
0
infinite
0
--
csml-variable:Double
m38
0
infinite
0
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
synthetic LXR agonist
--
e40
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m40
0
infinite
0
--
csml-variable:Double
m41
0
infinite
0
--
LPS: TLR4
--
e42
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m42
0
infinite
0
--
NF-kappaB {activated}
--
e43
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m44
10
infinite
0
TRANSPATH | MO000000058 |
--
cholesterol removing genes
--
e44
cso30:c:mRNA
cso30:i:CC_Nucleolus
--
--
csml-variable:Double
m45
0
infinite
0
--
Listeria ligand: InlA R
--
e45
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m46
0
infinite
0
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
M-CSF: M-CSFR
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
PMID: 18251777 Macrophages incubated in medium containing lipo-MDP increased DNA fragmentation.
p10
p10
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c14 : 1
m155666*0.1
nodelay
--
0
PMID: 18251777 After LPS administration cytokine production and the expression of LPS receptors, such as CD14 and macrophage scavenger receptor class A (MSR-A), were induced at lower levels in op/op mice than in littermate mice, indicating that deficient macrophage activation following LPS injection in op/op mice is associated with the decreased expression of CD14 and MSR-A in the liver.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c19 : 1
m155666*0.1
nodelay
--
0
PMID: 18251777 After LPS administration cytokine production and the expression of LPS receptors, such as CD14 and macrophage scavenger receptor class A (MSR-A), were induced at lower levels in op/op mice than in littermate mice, indicating that deficient macrophage activation following LPS injection in op/op mice is associated with the decreased expression of CD14 and MSR-A in the liver.
p12
p12
cso30:i:CE_CellSurvival_InhibitionOfApoptosis_
cso30:i:CC_Cytosol
--
--
PMID: 18251777 GM-CSF is also a hematopoietic growth factor that stimulates the survival, proliferation, differentiation, and function of myeloid cells and their precursors, particularly neutrophils and monocyte/macrophages.
PMID: 18251777 GM-CSF is also a hematopoietic growth factor that stimulates the survival, proliferation, differentiation, and function of myeloid cells and their precursors, particularly neutrophils and monocyte/macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c25 : 1
stoichiometry:c26 : 1
m16*m39415*0.1
nodelay
--
0
PMID: 18251777 Complement receptor type 3 (CR3) and the receptor of internalin A (InlA) mediate the uptake of Listeria.
p15
p15
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c28 : 1
stoichiometry:c45 : 1
m20155*m2549*0.1
nodelay
--
0
PMID: 18251777, 7867067 A class A type III macrophage receptor with a collagenous structure (MARCO) is a trimeric membrane glycoprotein mediating the uptake of chemically modified low-density lipoproteins.
p16
p16
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
stoichiometry:c31 : 1
m155666*m359003*0.1
nodelay
--
0
PMID: 18251777 Type I and type II MSR-A recognize a variety of polyanions such as chemically modified lipoproteins, LPS of Gramnegative bacteria, and lipoteichoic acid of Gram-positive bacteria, suggesting a role in host defense. PMID: 18251777 LPS is known to bind to several receptors on macrophages, including CD14 and MSR-A, and stimulates macrophages to release various nflammatory mediators.
p17
p17
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m2828*m155666*0.1
nodelay
--
0
PMID: 18251777 LPS is known to bind to several receptors on macrophages, including CD14 and MSR-A, and stimulates macrophages to release various nflammatory mediators.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
stoichiometry:c37 : 1
m359003*m22*0.1
nodelay
--
0
PMID: 18251777 Type I and type II MSR-A recognize a variety of polyanions such as chemically modified lipoproteins, LPS of Gramnegative bacteria, and lipoteichoic acid of Gram-positive bacteria, suggesting a role in host defense.
p19
p19
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c40 : 1
m359003*m2549*0.1
nodelay
--
0
PMID: 18251777 Type I and type II MSR-A recognize a variety of polyanions such as chemically modified lipoproteins, LPS of Gramnegative bacteria, and lipoteichoic acid of Gram-positive bacteria, suggesting a role in host defense.
PMID: 18251777 These results imply that the intralysosomal accumulation of MDP generates signals to induce macrophage apoptosis.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m155666*0.1
nodelay
--
0
PMID: 18251777 LPS-induced expression of cytokines in the liver was similar in MSR-A+/+and MSR-A-/? mice, but levels of IL-1beta expression and serum IL-1beta were lower in MSR-A-/? mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m20*0.1
nodelay
--
0
PMID: 18251777 LPS-induced expression of cytokines in the liver was similar in MSR-A+/+and MSR-A-/? mice, but levels of IL-1beta expression and serum IL-1beta were lower in MSR-A-/? mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c46 : 1
m12*0.1
nodelay
--
0
PMID: 18251777 Expression of scavenger receptors is enhanced by macrophage colony-stimulating factor (M-CSF) and granulocyte?macrophage colony-stimulating factor (GM-CSF).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c47 : 1
m6*0.1
nodelay
--
0
PMID: 18251777 Expression of scavenger receptors is enhanced by macrophage colony-stimulating factor (M-CSF) and granulocyte?macrophage colony-stimulating factor (GM-CSF).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m341431*m19*0.1
nodelay
--
0
PMID: 18251777 Scavenger receptors uptake oxidized low-density lipoprotein (oxLDL) and intracellular accumulation of cholesterol stimulate LXRalpha.
p25
p25
cso30:i:ME_Accumulation
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
PMID: 18251777 Scavenger receptors uptake oxidized low-density lipoprotein (oxLDL) and intracellular accumulation of cholesterol stimulate LXRalpha.
p26
p26
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m360460*0.1
nodelay
--
0
PMID: 18251777 Scavenger receptors uptake oxidized low-density lipoprotein (oxLDL) and intracellular accumulation of cholesterol stimulate LXRalpha.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
stoichiometry:c58 : 1
m28*m27*0.1
nodelay
--
0
PMID: 18251777, 14527307 This modified enzyme is endocytosed after it binds to cell-surface mannose receptors and is subsequently delivered to lysosomes where it supplements the defective enzyme.
p28
p28
cso30:i:ME_MetabolicReaction
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c59 : 1
stoichiometry:c61 : 1
m360460*m36*0.1
nodelay
--
0
PMID: 18251777 Liver X receptors (LXR) are also involved in cholesterol metabolism in macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m2283*m36*0.1
nodelay
--
0
PMID: 18251777, 7935418, 7744246 LXR are nuclear receptors initially identified in the liver that form a functional heterodimer with the retinoid X receptor (RXR) to recognize and bind to its hormone response elements.
p3
p3
cso30:i:ME_MetabolicReaction
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c3 : 1
stoichiometry:c4 : 1
stoichiometry:c5 : 1
m6272*m11*0.1
nodelay
--
0
PMID: 18251777 Heme oxygenase 1 (HO-1) in macrophages and hepatocytes plays a key role in bilirubin metabolism. Senescent or denatured erythrocytes incorporated by Kupffer cells and non-heme protein in hepatocytes are a major source of bilirubin.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m32*m33*0.1
nodelay
--
0
PMID: 18251777, 7935418, 7744246 LXR are nuclear receptors initially identified in the liver that form a functional heterodimer with the retinoid X receptor (RXR) to recognize and bind to its hormone response elements.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c70 : 1
stoichiometry:c69 : 1
m30*m35*0.1
nodelay
--
0
PMID: 18251777, 9794827, 12449021, 12193651 LXR are activated by a number of oxidized derivatives of cholesterol (oxysterols) and promote the synthesis of ABCA1 and other transporters, which reduce intracellular levels of cholesterol and thus protect against atherosclerosis.
p32
p32
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
stoichiometry:c74 : 1
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c71 : 1
m95583*m36*0.1
nodelay
--
0
PMID: 18251777, 9794827, 12449021, 12193651 LXR are activated by a number of oxidized derivatives of cholesterol (oxysterols) and promote the synthesis of ABCA1 and other transporters, which reduce intracellular levels of cholesterol and thus protect against atherosclerosis. PMID: 18251777 A potent TLR3 agonist, poly I:C, and a TLR4 agonist, lipid A, selectively inhibit the synthesis of ABCA1 and other cholesterol efflux mediators, when macrophages are stimulated with synthetic LXR agonists.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c77 : 1
m41*0.1
nodelay
--
0
PMID: 18251777 We also confirmed that LXRa expression was markedly decreased in the rat liver after zymosan injection and we therefore cultured human monocytes in the presence of LPS or zymosan.
p34
p34
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c81 : 1
stoichiometry:c80 : 1
m43*m42*0.1
nodelay
--
0
PMID: 18251777, 12524534 LXR agonist inhibits LPS-TLR4 activation of nuclear factor-kappaB target genes, including inflammatory cytokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
stoichiometry:c82 : 1
m44*0.1
nodelay
--
0
PMID: 18251777, 12524534 LXR agonist inhibits LPS-TLR4 activation of nuclear factor-kappaB target genes, including inflammatory cytokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m36*0.1
nodelay
--
0
PMID: 18251777 LXRalpha upregulates several target genes that remove cholesterol from macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m15*m16*0.1
nodelay
--
0
PMID: 18251777 Complement receptor type 3 (CR3) and the receptor of internalin A (InlA) mediate the uptake of Listeria.
p4
p4
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c7 : 1
stoichiometry:c8 : 1
m89*m76*0.1
nodelay
--
0
PMID: 18251777 The effects of M-CSF are mediated by the M-CSF receptor (M-CSFR), encoded by the c-fms proto-oncogene.
PMID: 18251777, 8426088 These results indicate that the differentiation and maturation of tissue macrophages are mediated by M-CSF, but dendritic cell differentiation is controlled by other factor(s) than M-CSF, most probably by GM-CSF.
PMID: 18251777, 8426088 These results indicate that the differentiation and maturation of tissue macrophages are mediated by M-CSF, but dendritic cell differentiation is controlled by other factor(s) than M-CSF, most probably by GM-CSF. PMID: 18251777 GM-CSF is also a hematopoietic growth factor that stimulates the survival, proliferation, differentiation, and function of myeloid cells and their precursors, particularly neutrophils and monocyte/macrophages.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m12*0.1
nodelay
--
0
PMID: 18251777 GM-CSF acts as a stimulator of terminal differentiation of alveolar macrophages, principally through PU.1 expression.
PMID: 18251777 GM-CSF acts as a stimulator of terminal differentiation of alveolar macrophages, principally through PU.1 expression. PMID: 18251777 Thus, GM-CSF acts as a stimulator of terminal differentiation of alveolar macrophages, principally through PU.1 expression.
p9
p9
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c18 : 1
stoichiometry:c17 : 1
m155666*m13*0.1
nodelay
--
0
PMID: 18251777 After LPS administration cytokine production and the expression of LPS receptors, such as CD14 and macrophage scavenger receptor class A (MSR-A), were induced at lower levels in op/op mice than in littermate mice, indicating that deficient macrophage activation following LPS injection in op/op mice is associated with the decreased expression of CD14 and MSR-A in the liver.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--